Search Results - Rosenberg, Amy S.
- Showing 1 - 20 results of 40
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation by Cardone, Marco, Yano, Masahide, Rosenberg, Amy S., Puig, Montserrat
Published 2020Text -
7
-
8
-
9
Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort by Desai, Ankit K., Baloh, Carolyn H., Sleasman, John W., Rosenberg, Amy S., Kishnani, Priya S.
Published 2020Text -
10
-
11
-
12
Letter to the Editors: Concerning “CRIM-Negative Pompe Disease Patients with Satisfactory Clinical Outcomes on Enzyme Replacement Therapy” by Al Khallaf et al by Prater, Sean N., Banugaria, Suhrad G., Morgan, Claire, Sung, Crystal C., Rosenberg, Amy S., Kishnani, Priya S.
Published 2013Text -
13
-
14
-
15
-
16
-
17
Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: Need for agents to target antibod... by Banugaria, Suhrad G., Patel, Trusha T., Mackey, Joanne, Das, Stuti, Amalfitano, Andrea, Rosenberg, Amy S., Charrow, Joel, Chen, Y.-T., Kishnani, Priya S.
Published 2012Text -
18
-
19
Induction of Murine Acquired Immunodeficiency Syndrome (MAIDS) in Allophenic Mice Generated from Strains Susceptible and Resistant to Disease by Sechler, Joan M.G., Lawler, Ann, Hartley, Janet W., Morse, Herbert C., McCarty, Thomas C., Swofford, Ruth, Rosenberg, Amy S.
Published 1996Text -
20